These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 32395349)

  • 1. Understanding and Improving
    Lowentritt BH; Kipper MS
    Prostate Cancer; 2020; 2020():1929565. PubMed ID: 32395349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of
    Scarsbrook AF; Bottomley D; Teoh EJ; Bradley KM; Payne H; Afaq A; Bomanji J; van As N; Chua S; Hoskin P; Chambers A; Cook GJ; Warbey VS; Han S; Leung HY; Chau A; Miller MP; Gleeson FV;
    Int J Radiat Oncol Biol Phys; 2020 Jun; 107(2):316-324. PubMed ID: 32068113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of
    Andriole GL; Scarsbrook AF; Savir-Baruch B;
    Urol Oncol; 2023 Jun; 41(6):293.e1-293.e7. PubMed ID: 37121865
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Armstrong JM; Martin CR; Dechet C; Morton K; Evans D; Ambrose J; Maughan BL; O'Neil B; Lowrance W
    Urol Oncol; 2020 Jul; 38(7):636.e1-636.e6. PubMed ID: 32317221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recurrent prostate cancer detection with anti-3-[(18)F]FACBC PET/CT: comparison with CT.
    Odewole OA; Tade FI; Nieh PT; Savir-Baruch B; Jani AB; Master VA; Rossi PJ; Halkar RK; Osunkoya AO; Akin-Akintayo O; Zhang C; Chen Z; Goodman MM; Schuster DM
    Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1773-83. PubMed ID: 27091135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reader Training for the Restaging of Biochemically Recurrent Prostate Cancer Using
    Miller MP; Kostakoglu L; Pryma D; Yu JQ; Chau A; Perlman E; Clarke B; Rosen D; Ward P
    J Nucl Med; 2017 Oct; 58(10):1596-1602. PubMed ID: 28385791
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of 18F-fluciclovine PET/CT on salvage radiotherapy plans for men with recurrence of prostate cancer postradical prostatectomy.
    Payne H; Bomanji J; Bottomley D; Scarsbrook AF; Teoh EJ;
    Nucl Med Commun; 2022 Feb; 43(2):201-211. PubMed ID: 34669678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between
    Saarinen I; Jambor I; Kim M; Kuisma A; Kemppainen J; Merisaari H; Eskola O; Koskenniemi AR; Perez IM; Boström P; Taimen P; Minn H
    EJNMMI Res; 2019 May; 9(1):50. PubMed ID: 31152256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Performance of 18F-Fluciclovine in Detection of Prostate Cancer Bone Metastases.
    Chau A; Gardiner P; Colletti PM; Jadvar H
    Clin Nucl Med; 2018 Jul; 43(7):e226-e231. PubMed ID: 29762238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-Fluciclovine PET/CT Detection of Recurrent Prostate Carcinoma in Patients With Serum PSA ≤ 1 ng/mL After Definitive Primary Treatment.
    England JR; Paluch J; Ballas LK; Jadvar H
    Clin Nucl Med; 2019 Mar; 44(3):e128-e132. PubMed ID: 30589673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of fluciclovine (
    Akin-Akintayo O; Tade F; Mittal P; Moreno C; Nieh PT; Rossi P; Patil D; Halkar R; Fei B; Master V; Jani AB; Kitajima H; Osunkoya AO; Ormenisan-Gherasim C; Goodman MM; Schuster DM
    Eur J Radiol; 2018 May; 102():1-8. PubMed ID: 29685521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolated Hepatic Metastasis of Prostate Cancer with Variable
    Sorra E; Aziz MU; Peng F
    Nucl Med Mol Imaging; 2020 Feb; 54(1):53-57. PubMed ID: 32206132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploratory study of
    Akintayo AA; Bilen MA; Abiodun-Ojo OA; Kucuk O; Carthon B; Chen Z; Jani AB; Parent EE; Schuster DM
    Am J Nucl Med Mol Imaging; 2021; 11(3):218-229. PubMed ID: 34235000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical utility of
    Marcus C; Abiodun-Ojo OA; Jani AB; Schuster DM
    Am J Nucl Med Mol Imaging; 2021; 11(5):406-414. PubMed ID: 34754611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Recurrent Prostate Cancer With
    Selnæs KM; Krüger-Stokke B; Elschot M; Johansen H; Steen PA; Langørgen S; Aksnessæther BY; Indrebø G; Sjøbakk TAE; Tessem MB; Moestue SA; Knobel H; Tandstad T; Bertilsson H; Solberg A; Bathen TF
    Front Oncol; 2020; 10():582092. PubMed ID: 33425735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multisite Experience of the Safety, Detection Rate and Diagnostic Performance of Fluciclovine (
    Bach-Gansmo T; Nanni C; Nieh PT; Zanoni L; Bogsrud TV; Sletten H; Korsan KA; Kieboom J; Tade FI; Odewole O; Chau A; Ward P; Goodman MM; Fanti S; Schuster DM; Willoch F
    J Urol; 2017 Mar; 197(3 Pt 1):676-683. PubMed ID: 27746282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic performance of
    Teyateeti A; Teyateeti A; Ravizzini GC; Xu G; Tang C; Tu SM; Macapinlac HA; Lu Y
    Am J Nucl Med Mol Imaging; 2021; 11(2):87-98. PubMed ID: 34079638
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Abiodun-Ojo OA; Akintayo AA; Akin-Akintayo OO; Tade FI; Nieh PT; Master VA; Alemozaffar M; Osunkoya AO; Goodman MM; Fei B; Schuster DM
    J Nucl Med; 2019 Nov; 60(11):1531-1536. PubMed ID: 30954940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse: A Comparison to 11C-Choline PET/CT.
    Nanni C; Schiavina R; Brunocilla E; Boschi S; Borghesi M; Zanoni L; Pettinato C; Martorana G; Fanti S
    Clin Nucl Med; 2015 Aug; 40(8):e386-91. PubMed ID: 26053708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.